Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Document Type
Year range
1.
Annals of Clinical and Analytical Medicine ; 13(11):1247-1251, 2022.
Article in English | EMBASE | ID: covidwho-2287413

ABSTRACT

Aim: There is no study that have assessed face-to-face using the multidimensional pain scale in COVID-19 patients with musculoskeletal pain. This study aimed to reveal the pain region, character and severity in COVID-19 patients with musculoskeletal pain. Material(s) and Method(s): This cross-sectional study was carried out in 214 patients who had a positive result of the polymerase chain reaction test within the last five days and at least one musculoskeletal pain symptom, such as fatigue, myalgia, and arthralgia/polyarthralgia. The cases were divided into groups as clinically severe and non-severe. Evaluations were made on the first day of admission. Myalgia symptoms were classified as diffuse and local. The McGill Pain Questionnaire was used for pain regions and caharacters while the Visual Analog Scale (VAS) was for pain intensity. Result(s): The frequency of involvement was myalgia (96.3%), fatigue (77.6%) and polyarthralgia (62.6%), respectively. The diffuse myalgia was (53.3%) in all patients. The mean myalgia VAS score in the non-severe group was 5.88+/-1.83 and 6.25+/-1.24 in the severe group (p=0.192). The most common pain areas were the back, feet, and knees respectively, and throbbing (40.7%), aching (30.8%), and pricking (26.1%) were the most common characteristics. The suffocating character of the pain was significantly higher in the severe group (p<0.05). Discussion(s): Defining disease-specific pain regions, character and severity in COVID-19 patients with musculoskeletal pain is important in managing possible chronic pain.Copyright © 2022, Derman Medical Publishing. All rights reserved.

2.
Annals of Clinical and Analytical Medicine ; 13(5):563-567, 2022.
Article in English | Web of Science | ID: covidwho-1869978

ABSTRACT

Aim: In this study, we aimed to determine the effects of a home exercise program on patients who treated for COVID-19 in the pandemic ward. Material and Methods: In this randomized, clinical, single-blinded, controlled study, 82 patients who were discharged after completing their COVID-19 treatment were included in the study, and demographic data were recorded by dividing them Into two groups as experimental (n-42) and control (n=40). Joint range of motion (ROM) and balance exercises were recommended for the experimental group as a home exercise program, while the control group did not receive any intervention. The home exercise program was implemented 5 days a week for 4 weeks. All the patients were evaluated in terms of quality of life (Nottingham Health Profile (NHP)). kinesiophobia (Tampa Scale of Kinesiophobia), balance (Berg Balance Scale). pain (Visual Analog Scale) before and after the intervention. Results: In both groups, a statistically significant difference was observed in the quality of life, balance and pain levels after the intervention (p<0.05). After the intervention, there was a statistically significant improvement in kinesiophobia in the experimental group (p<0.05), no statistically significant difference was found in kinesiophobia in the control group (p<0.05). In the comparison between the groups after intervention, a statistically significant difference was observed in terms of quality of life (NHP part 2), kinesiophobia, balance, with the results being in favor of the experimental group. Discussion: ROM and balance exercises for post-COVID-19 patients at the time of discharge are effective in improving quality of life, balance and kinesiophobia, but their effects on pain remain unclear.

SELECTION OF CITATIONS
SEARCH DETAIL